Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EPHX2 | P34913 | 7/20 | 1.00 |
| ▸ | FAAH | O00519 | 3/20 | 0.83 |
| ▸ | MEN1 | O00255 | 2/20 | 0.83 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.83 |
| ▸ | CNR2 | P34972 | 3/20 | 0.79 |
| ▸ | CNR1 | P21554 | 2/20 | 0.79 |
| ▸ | GAA | P10253 | 1/20 | 0.74 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.67 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.67 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.67 |
| ▸ | POLB | P06746 | 1/20 | 0.64 |
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.64 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.62 |
| ▸ | HPGD | P15428 | 1/20 | 0.62 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28136678 | 1.00 | EPHX2 (1.00) | EPHX2FAAHMEN1KMT2ACNR2 | |
| SCHEMBL2088173 | 1.00 | EPHX2 (1.00) | EPHX2FAAHMEN1KMT2ACNR2 | |
| SCHEMBL16714726 | 1.00 | EPHX2 (1.00) | EPHX2FAAHMEN1KMT2ACNR2 | |
| SCHEMBL2166861 | 1.00 | EPHX2 (1.00) | EPHX2FAAHMEN1KMT2ACNR2 | |
| SCHEMBL29052372 | 1.00 | EPHX2 (1.00) | EPHX2FAAHMEN1KMT2ACNR2 | |
| SCHEMBL5696750 | 1.00 | EPHX2 (1.00) | EPHX2FAAHMEN1KMT2ACNR2 | |
| SCHEMBL2524088 | 1.00 | EPHX2 (1.00) | EPHX2FAAHMEN1KMT2ACNR2 | |
| N-Benzyldodecanamide SCHEMBL3977374 | 1.00 | EPHX2 (1.00) | EPHX2FAAHMEN1KMT2ACNR2 | |
| SCHEMBL5471650 | 1.00 | EPHX2 (1.00) | EPHX2FAAHMEN1KMT2ACNR2 | |
| SCHEMBL1516109 | 0.98 | EPHX2 (0.97) | EPHX2FAAHMEN1KMT2ACNR2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117510359-A | Synthesis method of N-benzyl-N-nonanamide compound | 中国人民解放军61699部队 | 2024-02-06 | — | — | CN | claimed |
| CN-1658866-A | Tri-substituted heteroaryls and methods of making and using the same | BIOGEN INC (US) | 2005-08-24 | — | — | CN | claimed |
| US-12351819-B2 | Method for removing undifferentiated pluripotent stem cells | ACADEMIA SINICA (TW) | 2025-07-08 | — | — | US | disclosed |
| CN-117510359-A | Synthesis method of N-benzyl-N-nonanamide compound | 中国人民解放军61699部队 | 2024-02-06 | — | — | CN | disclosed |
| CN-117510359-A | Synthesis method of N-benzyl-N-nonanamide compound | 中国人民解放军61699部队 | 2024-02-06 | — | — | CN | disclosed |
| CN-117510359-A | Synthesis method of N-benzyl-N-nonanamide compound | 中国人民解放军61699部队 | 2024-02-06 | — | — | CN | disclosed |
| CN-116041196-A | Novel method for catalytic synthesis of amide bond | 烟台南山学院 | 2023-05-02 | — | — | CN | disclosed |
| EP-2488032-B1 | PROSTAGLANDIN TRANSPORTER INHIBITORS AND USES THEREOF | EINSTEIN COLL MED (US) | 2016-11-02 | — | — | EP | disclosed |
| US-8309538-B2 | Capsaicinoid decontamination compositions and methods of use | KAPSO, LLC (US) | 2012-11-13 | — | — | US | disclosed |
| WO-2010144055-A1 | NOVEL COMPOUNDS AND USES THEREOF | NANYANG POLYTECHNIC (SG) | 2010-12-16 | — | — | WO | disclosed |
| US-20100086626-A1 | CAPSAICINOID DECONTAMINATION COMPOSITIONS AND METHODS OF USE | KAPSO, LLC | 2010-04-08 | — | — | US | disclosed |
| US-20080166310-A1 | Administration of 2-oxyacetamide compounds for promoting and/or inducing and/or stimulating the pigmentation of keratin materials and/or for limiting the depigmentation and/or bleaching thereof | L'OREAL (FR) | 2008-07-10 | — | — | US | disclosed |
| US-20080166310-A1 | Administration of 2-oxyacetamide compounds for promoting and/or inducing and/or stimulating the pigmentation of keratin materials and/or for limiting the depigmentation and/or bleaching thereof | L'OREAL (FR) | 2008-07-10 | — | — | US | disclosed |
| US-20060198806-A1 | Capsaicinoid decontamination compositions and methods of use | KAPSO, LLC | 2006-09-07 | — | — | US | disclosed |
| CN-1658866-A | Tri-substituted heteroaryls and methods of making and using the same | BIOGEN INC (US) | 2005-08-24 | — | — | CN | disclosed |
| US-20010051184-A1 | METHOD FOR USING SOLUBLE CURCUMIN TO INHIBIT PHOSPHORYLASE KINASE IN INFLAMMATORY DISEASES | NEUVOLA II, LLC | 2001-12-13 | — | — | US | disclosed |
| WO-2000070949-A1 | METHOD FOR USING SOLUBLE CURCUMIN TO INHIBIT PHOSPHORYLASE KINASE IN INFLAMMATORY DISEASES | HENG MADALENE C Y (US) | 2000-11-30 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20010051184-A1 | METHOD FOR USING SOLUBLE CURCUMIN TO INHIBIT PHOSPHORYLASE KINASE IN INFLAMMATORY DISEASES | CAMK1, PNCK, CAMK1D | EPHX2 2490/4885FAAH 701/4885MEN1 3911/4885 |
| US-12351819-B2 | Method for removing undifferentiated pluripotent stem cells | ALPG, UGGT1, GYPA | EPHX2 237/4885FAAH 4572/4885MEN1 3780/4885 |
| US-20080166310-A1 | Administration of 2-oxyacetamide compounds for promoting and/or inducing and/or stimulating the pigmentation of keratin materials and/or for limiting the depigmentation and/or bleaching thereof | KRT18, TYR, CRYAA | EPHX2 1447/4885FAAH 859/4885MEN1 4421/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.